ODDB.org: Open Drug Database

Neuraxpharm Switzerland AG - Briumvi 25 mg/ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	69599	Sequence	01
Product name	Briumvi 25 mg/ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification
Introduction of Sequence	06.02.2025

Composition

ublituximabum 150 mg, natrii chloridum, natrii citras dihydricus, polysorbatum 80, acidum hydrochloridum concentratum, aqua ad iniectabile ad solutionem pro 6 ml corresp. natrium 31.57 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Ublituximabum	150mg / 6ml

Inactive agents
Acidum Hydrochloridum Concentratum
Sodium Chloride
Natrii Citras Dihydricus
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		PR	PR	A		No
002	3	PR	PR	A		No

2025	©ywesee GmbH